SITC strives to launch effective initiatives in order to accelerate the delivery of new immunotherapies to cancer patients around the world. In an effort led by SITC Past President, Bernard Fox, PhD, a collaborative group of international and domestic organizations similarly interested in promoting research and translation of cancer immunotherapy prepared a joint publication that defines the critical hurdles in cancer immunotherapy. This manuscript was published in the Journal of Translational Medicine. To access the full manuscript, click here.
In an exciting and first-of-its-kind collaboration, SITC convened the World Immunotherapy Council (WIC) inaugural summit February 21-24, 2012 in Curacao. Scientific sessions at the meeting focused on several of the hurdles identified in the "Defining the Critical Hurdles in Cancer Immunotherapy" manuscript (see above), including mechanisms of immune escape, immunological monitoring, and prognostic and predictive biomarkers. This summit provided a forum to facilitate the rapid development and global dissemination of cancer immunotherapies through international scientific exchange.
